Sector consensus Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Delayed Börse Stuttgart 16:18:51 29/09/2026 BST			5-day change	1st Jan Change
0.1310 ^EUR	0.00%		-18.12%	-36.41%

08-14	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
WUXI APPTEC CO., LTD.			187.07	+15.62%	18
ARGENX SE			1,175.3	+22.39%	15
WUXI BIOLOGICS (CAYMAN) INC.			49.73	+9.04%	24
INSMED INCORPORATED			199.04	+69.15%	23
BIONTECH SE			103.07	+18.27%	20
GENMAB A/S			2,453.79	+6.59%	15
PHARMAESSENTIA CORPORATION			1,397.26	+20.98%	8
EXELIXIS, INC.			53.69	-8.02%	16
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			619.67	+36.13%	19
SUMMIT THERAPEUTICS INC.			21.61	+84.84%	13
MADRIGAL PHARMACEUTICALS, INC.			682.11	+31.93%	18
AKESO, INC.			133.02	+68.96%	21
ARROWHEAD PHARMACEUTICALS, INC.			107.23	+63.81%	13
CYTOKINETICS, INCORPORATED			109.9	+66.11%	20
IMMUNITYBIO, INC.			12.75	+49.65%	4
VAXCYTE, INC.			108.67	+86.49%	9
REMEGEN CO., LTD.			100.11	+64.31%	16
SPYRE THERAPEUTICS, INC.			120.08	+39.97%	13
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	-	-	-	-	-
Average			424.12	+41.46%	16
Weighted average by Cap.			524.09	+30.91%	17